Position in ABBV
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$3,268,048
+$512,885 QoQ
Shares Held
12,987
+2.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#1,590
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rehmann Capital Advisory Group holds $37,318,224 across 12 Drug Manufacturers - General names. ABBV ranks #5 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
38,703 | $9,829,400 | |
| 2 | LLY |
ELI LILLY & Co
|
5,246 | $6,292,210 | |
| 3 | MRK |
Merck & Co., Inc.
|
29,611 | $3,805,013 | |
| 4 | PFE |
Pfizer Inc
|
152,066 | $3,661,749 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
12,987 | $3,268,048 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
42,344 | $2,439,861 | |
| 7 | AMGN |
Amgen Inc
|
6,083 | $2,202,775 | |
| 8 | AZN |
Astrazeneca PLC
|
10,283 | $1,949,862 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,268,048 | 12,987 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $2,755,163 | 12,668 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,172,583 | 13,885 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $3,326,766 | 14,368 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,762,025 | 14,880 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $3,087,696 | 14,737 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,562,078 | 14,418 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,738,455 | 13,867 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $2,443,645 | 14,247 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,406,997 | 13,218 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,020,498 | 13,038 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,931,221 | 12,956 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,758,361 | 13,051 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $2,106,393 | 13,217 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,051,962 | 12,697 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,793,716 | 13,365 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,149,447 | 14,034 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,100,621 | 12,958 | Shares | Sole | 2022-06-03 | |
| 2021-12-31 | $1,643,756 | 12,140 | Shares | Sole | 2022-03-02 | |
| 2021-09-30 | $1,651,489 | 15,310 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,395,046 | 12,385 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,282,948 | 11,855 | Shares | Sole | 2021-05-26 | |
| 2020-12-31 | $1,190,757 | 11,113 | Shares | Sole | 2021-02-19 | |
| 2020-09-30 | $1,132,275 | 12,927 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $1,203,883 | 12,262 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $940,032 | 12,338 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||